Chemours Q3 2024 Adj. EPS $0.40 Beats $0.28 Estimate, Sales $1.500B Beat $1.442B Estimate
CCNovember 4, 2024
Read more →RBC Capital Maintains Outperform on Chemours, Raises Price Target to $48
CCMay 4, 2022
Read more →Chemours: Q1 Earnings Insights
CCChemours (NYSE:CC) reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by 58.7%, reporting an EPS of $1.46 versus an estimate of $0.92.
May 2, 2022
Read more →Chemours Raises FY22 Adj. EBITDA Guidance From $1.3B-$1.425B To $1.475B-$1.575B
CCMay 2, 2022
Read more →Chemours Q1 Adj. EPS $1.46 Beats $0.92 Estimate, Sales $1.76B Beat $1.57B Estimate
CCMay 2, 2022
Read more →